Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$100.0M
total disclosed, rounds participated
Stages
—
Portfolio · 1
Investment activity
1 portfolio exit on record.
Portfolio by sector
Fintech & Insurtech1
Health Tech & Life Sciences1
Q&A
- What was iGlobe Partners' most recent exit?
- iGlobe Partners exited C2i Genomics in January 2024 when it was acquired by Veracyte for $95M.
- Which sectors does iGlobe Partners primarily invest in?
- iGlobe Partners has invested in Health Tech & Life Sciences and Fintech & Insurtech sectors, with one portfolio company in each.
- Can you name some of iGlobe Partners' portfolio companies?
- iGlobe Partners' portfolio includes C2i Genomics, a whole-genome cancer treatment intelligence platform, and Five Sigma, an AI insurance claim management platform.
- What is the typical investment range for iGlobe Partners?
- iGlobe Partners typically invests between $16M and $100M.
- When did iGlobe Partners make its most recent investments?
- iGlobe Partners made investments in April 2021 and September 2021, according to startupim data.
- What is the funding stage focus for iGlobe Partners' investments?
- iGlobe Partners has participated in both A Round and B Round funding stages.